Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-05-21

Clinical Trial Update: Canthaxanthin Retinopathy: A Long-term Observation

View source ↗

Summary

A long-term observational update from a completed study on canthaxanthin retinopathy, documenting safety and outcome data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Canthaxanthin (canthaxanthin)

Snippet

Sponsor: University of Cologne | Conditions: Canthaxanthin Retinopathy | Status: COMPLETED